Veenendaal, January 27th, 2022 – MolGen B.V. of Veenendaal (NL) is excited to announce its participation in SLAS 2022, February 5-9. SLAS 2022, organized by SLAS international conference and exhibition to highlight life science discoveries, research and innovations in laboratory technology. With 80 scientific talks and exhibitions, it brings a unique opportunity to inspire life science researchers to share discovery and thought-provoking research, to connect with developers and top-tier providers of laboratory automation technology, and advance scientific innovation. MolGen is looking forward to being a part of this premier international conference to share its innovative diagnostic workflows and connect to the esteemed network of academic, industry, government life science researchers and laboratory automation technology providers.
MolGen is using this conference as an opportunity to showcase its high-tech laboratory automation technology, customized diagnostic workflow and its latest products and services to technology professionals and life science researchers. During this conference, MolGen will display its complete diagnostics workflow and molecular automation product offerings for human diagnostics and pharmaceutical sciences that are available worldwide.
In the areas of human diagnostics, industry and laboratory sciences, MolGen offers integrated state-of-the-art molecular purification products and systems that achieve greater efficiency, automation and scaling-up in human disease testing and diagnosis. Its extraction and testing solutions, products and equipment are designed to achieve high throughput, increased automation, reduced time to result, high yields and effective reproducibility. MolGen’s systems and consumables are versatile, efficient, highly accurate, reliable and universally applicable to empower next-generation research genetics and improve the health and wellbeing of all.
“Attending the SLAS conference will be the perfect opportunity to share our customisable laboratory workflows. Our products ensure greater efficiency, automation and safety as a standard, and solve the problem of lab personnel shortage by allowing high throughput robotics for large-scale molecular testing. by allowing high throughput for large-scale molecular diagnostics. Solving the need for high throughput testing, our scalable reagents, systems and workflows represent true innovations in laboratory technology that will transform the day-to-day of professional laboratories worldwide,“ said Niels Kruize, MolGen CCO.
